Plastopil Hazorea Company (PPIL) Fair Value & Analysis
Consumer Cyclical · Il · Market cap 73.6M ILA
Fair value as of: Jun 24, 2026
Analysis
Plastopil Hazorea Company (PPIL) currently trades at 5.29 ILA, while our model-based Fair Value estimate is 3.64 ILA — implying the stock looks roughly 31.2% overvalued today. We read business quality at 92/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Plastopil Hazorea Company Ltd engages in the development, manufacture, and sale of flexible packaging solutions in Israel, the rest of Europe, the United States of America, and internationally. It operates through Packaging for the Food Industry; and Flexible Packaging for Industry segments. The company offers packaging solutions for chilled food, lidding films, thermoformable films, bags and liners, flow packs, and vacuum skin packaging; polyethylene sheets and sleeves; and other flexible packaging products. Its products are used for dairy, meat, poultry, seafood, fresh produce, ready meals, and miscellaneous applications. The company was formerly known as Plastopil Hazorea Agricultural Cooperative Society Ltd. and changed its name to Plastopil Hazorea Company Ltd in April 2005. Plastopil Hazorea Company Ltd was founded in 1960 and is based in Jezreel Valley, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Plastopil Hazorea Company (PPIL) undervalued?
What is the fair value of PPIL?
What is the quality score of PPIL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.